"Arthritis, Psoriatic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.
| Descriptor ID |
D015535
|
| MeSH Number(s) |
C05.116.900.853.625.800.424 C05.550.114.145 C05.550.114.865.800.424 C17.800.859.675.175
|
| Concept/Terms |
Arthritis, Psoriatic- Arthritis, Psoriatic
- Psoriasis, Arthritic
- Arthritic Psoriasis
- Psoriatic Arthritis
- Psoriasis Arthropathica
- Psoriatic Arthropathy
- Arthropathies, Psoriatic
- Arthropathy, Psoriatic
- Psoriatic Arthropathies
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Psoriatic".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Psoriatic".
This graph shows the total number of publications written about "Arthritis, Psoriatic" by people in this website by year, and whether "Arthritis, Psoriatic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 3 | 0 | 3 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 2 | 1 | 3 |
| 2022 | 1 | 0 | 1 |
| 2023 | 3 | 0 | 3 |
| 2024 | 2 | 0 | 2 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arthritis, Psoriatic" by people in Profiles.
-
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease: Current State. Rheum Dis Clin North Am. 2025 08; 51(3):537-544.
-
Effects of Secukinumab on Enthesiophyte and Erosion Progression in Psoriatic Arthritis: A One-Year Double-Blind, Randomized, Placebo-Controlled Trial Using High-Resolution Peripheral Quantitative Computed Tomography. Arthritis Rheumatol. 2025 Aug; 77(8):1015-1025.
-
Sequencing of Targeted Therapy in Psoriasis: Does it Matter? Am J Clin Dermatol. 2024 Sep; 25(5):795-810.
-
Some Drugs Have Two Faces: Paradoxical Colitis in a Patient with Psoriatic Arthritis Previously Treated with Etanercept and IL-17 Inhibitors. Dig Dis Sci. 2024 May; 69(5):1602-1607.
-
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug Saf. 2023 11; 46(11):1049-1071.
-
Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis - Authors' reply. Lancet Rheumatol. 2023 06; 5(6):e313.
-
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study. Lancet Rheumatol. 2023 04; 5(4):e200-e207.
-
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology. 2022 05; 162(6):1650-1664.e8.
-
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis. Adv Ther. 2020 01; 37(1):364-380.
-
Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Cardiovasc Res. 2019 03 15; 115(4):721-728.